Investigation learns combined doxorubicin and siRNA enhances immune response in cancer, suggesting a promising treatment strategy.
Restoring antitumor immunity while enhancing chemotherapy efficacy represents an optimistic strategy for cancer treatment. Enabling macrophage-mediated phagocytosis of cancer cells is pivotal for rehabilitating effective immune responses.However, its efficacy is...
No takes yet. Share an insight, caveat, or question.
Lian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: